These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11034276)

  • 41. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
    Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
    Sante; 1999; 9(6):341-4. PubMed ID: 10705312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams.
    Jacoby GA
    Infect Dis Clin North Am; 1997 Dec; 11(4):875-87. PubMed ID: 9421705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
    Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
    J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minor extended-spectrum beta-lactamases.
    Naas T; Poirel L; Nordmann P
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?
    Seiffert SN; Hilty M; Perreten V; Endimiani A
    Drug Resist Updat; 2013; 16(1-2):22-45. PubMed ID: 23395305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?
    Harris PN; Tambyah PA; Paterson DL
    Lancet Infect Dis; 2015 Apr; 15(4):475-85. PubMed ID: 25716293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon.
    Gangoué-Piéboji J; Bedenic B; Koulla-Shiro S; Randegger C; Adiogo D; Ngassam P; Ndumbe P; Hächler H
    J Clin Microbiol; 2005 Jul; 43(7):3273-7. PubMed ID: 16000447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of multidrug-resistant Gram-negative infections in children.
    Hsu AJ; Tamma PD
    Clin Infect Dis; 2014 May; 58(10):1439-48. PubMed ID: 24501388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restriction of cephalosporins and control of extended spectrum beta-lactamase producing gram negative bacteria in a neonatal intensive care unit.
    Murki S; Jonnala S; Mohammed F; Reddy A
    Indian Pediatr; 2010 Sep; 47(9):785-8. PubMed ID: 21048261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Delhi metallo-β-lactamase (NDM-1): an update.
    Shakil S; Azhar EI; Tabrez S; Kamal MA; Jabir NR; Abuzenadah AM; Damanhouri GA; Alam Q
    J Chemother; 2011 Oct; 23(5):263-5. PubMed ID: 22005056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular mechanisms of cephalosporin resistance in Gram-negative bacteria of the Enterobacteriaceae family].
    Sidorenko SV; Berezin AG; Ivanov DV
    Antibiot Khimioter; 2004; 49(3):6-16. PubMed ID: 15344391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.
    Ndugulile F; Jureen R; Harthug S; Urassa W; Langeland N
    BMC Infect Dis; 2005 Oct; 5():86. PubMed ID: 16225701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli.
    Huovinen S; Klossner ML; Katila ML; Huovinen P
    Scand J Infect Dis; 1989; 21(3):303-9. PubMed ID: 2667097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms.
    Schuetz AN; Reyes S; Tamma PD
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.